Anna Walentinsson

BioPharmaceuticals R&D
Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Phosphoproteomics distinguishes disease-specific mechanisms for human phospholamban cardiomyopathy reversible by RNA therapy.

Phosphoproteomics distinguishes disease-specific mechanisms for human phospholamban cardiomyopathy reversible by RNA therapy.

Journal: Signal transduction and targeted therapy

Published: December 15, 2025

RXFP1, the relaxin receptor: Lost and found in translation.

RXFP1, the relaxin receptor: Lost and found in translation.

Journal: Drug discovery today

Published: June 18, 2025

Matured hiPSC-derived cardiomyocytes possess dematuration plasticity.

Matured hiPSC-derived cardiomyocytes possess dematuration plasticity.

Journal: Journal of molecular and cellular cardiology plus

Published: August 21, 2024

Long noncoding RNA VENTHEART is required for ventricular cardiomyocyte specification and function.

Long noncoding RNA VENTHEART is required for ventricular cardiomyocyte specification and function.

Journal: Journal of molecular and cellular cardiology

Published: February 03, 2024

Cardiac biopsies reveal differences in transcriptomics between left and right ventricle in patients with or without diagnostic signs of heart failure.

Cardiac biopsies reveal differences in transcriptomics between left and right ventricle in patients with or without diagnostic signs of heart failure.

Journal: Scientific reports

Published: December 18, 2023

Epigenetic modulators link mitochondrial redox homeostasis to cardiac function in a sex-dependent manner.

Epigenetic modulators link mitochondrial redox homeostasis to cardiac function in a sex-dependent manner.

Journal: Nature communications

Published: August 03, 2022

Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease.

Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease.

Journal: Cardiovascular research

Published: June 19, 2022

A Combined Human in Silico and CRISPR/Cas9-Mediated in Vivo Zebrafish Based Approach to Provide Phenotypic Data for Supporting Early Target Validation.

A Combined Human in Silico and CRISPR/Cas9-Mediated in Vivo Zebrafish Based Approach to Provide Phenotypic Data for Supporting Early Target Validation.

Journal: Frontiers in pharmacology

Published: December 02, 2021

Unraveling the Metabolic Derangements Occurring in Non-infarcted Areas of Pig Hearts With Chronic Heart Failure.

Unraveling the Metabolic Derangements Occurring in Non-infarcted Areas of Pig Hearts With Chronic Heart Failure.

Journal: Frontiers in cardiovascular medicine

Published: August 04, 2021

MCPIP1 is a novel link between diabetogenic conditions and impaired insulin secretory capacity.

MCPIP1 is a novel link between diabetogenic conditions and impaired insulin secretory capacity.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: January 15, 2021

Identification of Proteins Associated with the Early Restoration of Insulin Sensitivity After Biliopancreatic Diversion.

Identification of Proteins Associated with the Early Restoration of Insulin Sensitivity After Biliopancreatic Diversion.

Journal: The Journal of clinical endocrinology and metabolism

Published: April 14, 2020

The inducible β5i proteasome subunit contributes to proinsulin degradation in GRP94-deficient β-cells and is overexpressed in type 2 diabetes pancreatic islets.

The inducible β5i proteasome subunit contributes to proinsulin degradation in GRP94-deficient β-cells and is overexpressed in type 2 diabetes pancreatic islets.

Journal: American journal of physiology. Endocrinology and metabolism

Published: April 08, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026